openPR Logo
Press release

Global OTC Vitamins & Dietary Supplements Market Insights, Region, Type, Application, Growth Rate, and Future Forecast till 2022: Industry Player:-BASF SE, DuPont, Koninklijke DSM N.V., Archer Daniels Midland Company., Lonza Group Ltd, Jubilant Life Scien

09-19-2018 02:40 PM CET | Health & Medicine

Press release from: Fact.MR

Global OTC Vitamins & Dietary Supplements Market Insights,

FactMR research firm has recently updated its massive report catalogue by adding a fresh study titled “OTC Vitamins & Dietary Supplements Market Forecast, Trend Analysis & Competition Tracking: Global Market insights 2017 to 2022”. This business intelligence study encapsulates vital details about the market current as well as future status during the forecast period of 2017-2022.Readers can expect holistic and comprehensive analysis on the OTC Vitamins & Dietary Supplements Market, which can be used for formulating effective business strategies. The report also targets important facets such as market drivers, challenges, latest trends, and opportunities associated to growth of manufacturers in global market for OTC Vitamins & Dietary Supplements.

Get a Free Sample Report here: https://www.factmr.com/connectus/sample?flag=S&rep_id=61

Over-the-counter (OTC) vitamins and dietary supplements are sold directly to consumers without any medical prescription. In many countries, OTC vitamins and dietary supplement products are regulated to ensure that they are effective and safe when used. Drug regulatory bodies allow manufacturers to formulate vitamin ingredients or combination of ingredients that are well tolerated and do not pose any risk of side effects or reactions.

As per the latest report published by Fact.MR, the global OTC Vitamins and Dietary Supplements Market is poised to increase at a CAGR of 6.7% between 2017 and 2022. A positive outlook on the role of OTC vitamin and dietary supplement products in improving body endurance and muscular strength is characterizing the widespread acceptance of such products. Also, the growth of the healthcare sector and introduction of favorable government policies focused on the development of healthcare is partly responsible for the increasing popularity of various over-the-counter (OTC) drugs including vitamins and dietary supplements. A notable growth in demand for OTC vitamins and dietary supplements has been observed in emerging countries such as China, Brazil and India due to increasing awareness among consumers about the benefits of such products. In addition, factors such as self-medication in cases of minor health issues, cost-effectiveness, and convenience of direct purchase are anticipated to drive the adoption and acceptance of OTC vitamins and dietary supplements over the next couple of years. Besides, drug makers are now concentrating on innovation in the formulation of such products in order to increase their functionalities. 

North America’s Leadership in Global OTC Vitamins and Dietary Supplement Market to Remain Unchallenged

The market for OTC vitamins and dietary supplements in North America is expected to remain highly lucrative during the forecast period. Currently, the region accounts for the largest share of the global market in terms of value. This is primarily owing to soaring demand for OTC drugs particularly in the U.S. Meanwhile, the market in Asia Pacific excluding Japan (APEJ) is also expected to witness an impressive growth over the forecast period (2017-2022). By 2017-end, Europe is estimated to account for more than 31% revenue share of the global market.

By function, use of OTC vitamins and dietary supplements will be robust for the general well-being of the body. Throughout the forecast period, global revenue from sales of OTC vitamins and dietary supplements for general well-being will continue to exhibit strong growth.

Check for getting full details about OTC Vitamins and Dietary Supplements Market: https://www.factmr.com/report/61/otc-vitamins-dietary-supplements-market

Pharmacies will remain the leading OCT channel for OTC vitamins and dietary supplements in 2017 and beyond. Pharmacies currently account for more than one-fourth share of the global market in terms of revenue. However, this OTC channel segment of the market is expected to lose 141 BPS toward the end of the forecast period.

Based on product form, global sales of OTC vitamin and dietary supplements capsules are expected to remain relatively higher over 2022.  Close to US$ 33 Bn worth of capsules are expected to be consumed worldwide by the end of the forecast period.

Competition Tracking

The global OTC vitamins and dietary supplements market remains highly competitive with several leading companies partaking in it, which include BASF SE, DuPont, Koninklijke DSM N.V., Archer Daniels Midland Company., Lonza Group Ltd, Jubilant Life Sciences Limited, Atrium Innovations, Inc., Sanofi S.A., Pfizer, Inc., GlaxoSmithKline plc, Dil Limited., Reckitt Benckiser LLC, CSPC Pharmaceutical Group Limited., Otsuka Holdings Co. Ltd., and Bactolac Pharmaceutical, Inc.

Ask our Industry Expert about this Report: https://www.factmr.com/connectus/sample?flag=AE&rep_id=61

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Follow Us on Linkedin: https://www.linkedin.com/company/factmr/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global OTC Vitamins & Dietary Supplements Market Insights, Region, Type, Application, Growth Rate, and Future Forecast till 2022: Industry Player:-BASF SE, DuPont, Koninklijke DSM N.V., Archer Daniels Midland Company., Lonza Group Ltd, Jubilant Life Scien here

News-ID: 1249024 • Views:

More Releases from Fact.MR

Bagless Vacuum Cleaners Market Is Predicted To Touch US$ 39.52 Billion By 2033: Fact.MR Report
Bagless Vacuum Cleaners Market Is Predicted To Touch US$ 39.52 Billion By 2033: …
The global demand for bagless vacuum cleaners is forecasted to experience a compound annual growth rate (CAGR) of 8% from 2023 to 2033. Consequently, the market for bagless vacuum cleaners worldwide is anticipated to surge from a value of US$ 18.3 billion in 2023 to reach US$ 39.52 billion by the end of 2033. The Bagless Vacuum Cleaner Industry sales study offers a comprehensive analysis on diverse features including production
NFC Chips Are Predicted To Reach US$ 7.6 Billion At A CAGR Of 15% By 2033: Fact.MR Report
NFC Chips Are Predicted To Reach US$ 7.6 Billion At A CAGR Of 15% By 2033: Fact. …
The global NFC chip market is valued at US$ 1.9 billion in 2023 and is forecasted to surge at a CAGR of 15% to reach a market size of US$ 7.6 billion by the end of 2033. The NFC Chip Industry sales study offers a comprehensive analysis on diverse features including production capacities, NFC Chip demand, product developments, sales revenue generation and NFC Chip market outlook across the globe. market research
Canned Beans Market Is Anticipated To Reach US$ 15 Billion By 2033: Fact.MR Report
Canned Beans Market Is Anticipated To Reach US$ 15 Billion By 2033: Fact.MR Repo …
The global canned beans market is valued at US$ 5.65 billion in 2023 and is projected to reach US$ 15 billion by the end of 2033, expanding at a high-value CAGR of 10.3% from 2023 to 2033. The Canned Beans Industry sales study offers a comprehensive analysis on diverse features including production capacities, Canned Beans demand, product developments, sales revenue generation and Canned Beans market outlook across the globe. market research
Plasma Fractionation Market Projected to Reach US$ 65 Billion by 2032, With 7.3% CAGR | Fact.MR
04-25-2024 | Health & Medicine
Fact.MR
Plasma Fractionation Market Projected to Reach US$ 65 Billion by 2032, With 7.3% …
The plasma fractionation market is projected to be valued US$ 32 billion in 2022. Moreover, growth is anticipated to pick up speed at a 7.3% CAGR over the assessment period of 2022-2032 and reach US$ 65 billion. The primary driver of the market's growth is the aging of the global population, which makes people more vulnerable to rare illnesses that call for the usage of blood derivatives. Furthermore, it is anticipated

All 5 Releases


More Releases for OTC

Deadline on Nov. 9th upcoming in Lawsuit for Investors in Harborside Inc. (OTC: …
The Shareholders Foundation announced that a deadline is coming up on November 9, 2020 in the lawsuit filed for certain investors of Harborside Inc. (OTC: HSDEF, OTC: HBORF). Investors who purchased shares of Harborside Inc. (OTC: HSDEF, OTC: HBORF) have certain options and there are strict and short deadlines running. Deadline: November 9, 2020. Harborside Inc. stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to
Investigation for Long-Term Investors in shares of Volkswagen AG (OTC: VWAGY / O …
An investigation on behalf of current long-term investors in shares of Volkswagen AG (OTC: VWAGY / OTC: VLKAF / OTC: VWAPY) was announced over potential breaches of fiduciary duties by certain officers and directors at Volkswagen AG. Investors who purchased shares of Volkswagen AG (OTC: VWAGY / OTC: VLKAF / OTC: VWAPY) and currently hold any of those Volkswagen AG shares have certain options and should contact the Shareholders Foundation at
OTC: VWAGY / OTC: VLKAF / OTC: VWAPY Shareholder Notice: Update in Lawsuit again …
The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in Volkswagen AG (OTC: VWAGY) (OTC: VWAPY) shares. Investors, who purchased shares of Volkswagen AG (OTC: VWAGY) (OTC: VLKAF) (OTC: VWAPY), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. On September 25, 2015, a lawsuit was filed against Volkswagen AG (alleged securities laws violations. The plaintiff claimed that the defendants
OTC Analgesics Market OTC analgesics market is projected to register a steady ex …
About OTC Analgesics Market The global OTC analgesics market is projected to register an above-average CAGR during 2017 to 2022. Global sales of OTC analgesics is estimated to account for nearly US$ 25,000 Mn revenues by 2022-end. Get Sample copy of this Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=75 The trend of using off-label drugs that are affordable and unapproved, but effective in treating diseases, has been witnessing an upsurge over the past few years.
03-14-2018 | Health & Medicine
Fact.MR
OTC Analgesics Market Report 2017-22: Pharmacy to Remain the Most Lucrative OTC …
A fresh study, covering “OTC Analgesics Market Forecast, Trend Analysis & Competition Tracking – Global Review 2017 to 2022” has been broadcasted to wide online repository of Fact MR, which presents deep focus on the healthcare market. This smart study contains precise data that offers a clear insight about market current scenario and future projections for the benefit of readers. Moreover, the study enclosed significant data which tends to make
The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects
ReportsWeb.com has announced the addition of the “Global OTC Drugs Market Research Report 2017” The report focuses on global major leading industry players with information such as company profiles, product picture and specification. GBI Research's latest report, "The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects" discusses trends in the over-the-counter (OTC) pharmaceuticals market and the commercial prospects for switching drugs from prescription-only to OTC status. The report assesses current